Pierre-Antoine Gourraud is a university professor and hospital practitioner at the Faculty of Medicine of Nantes University (France). He is an alumnus of the Biology Department of the École Normale Supérieure de Lyon. He arrived as a post-doctoral researcher in the Department of Neurology at the University of California (UCSF, USA) and left as an associate professor in 2018. Author of more than 220 publications cited over 15,000 times (h-index 60), his research sits at the crossroads of immunology, genetics, and health data processing. Close to the entrepreneurial world, he has worked with several health and biotechnology companies, providing them with his expertise.

Full Professor at the San Raffaele Roma Open University and Scientific Coordinator of the Interinstitutional Multidisciplinary Biobank, IRCCS San Raffaele Roma.

Ora Israel is Emeritus Professor of Imaging at the Rappaport School of Medicine, the Technion, in Haifa, Israel. In 2018 she retired from her position as director of Nuclear Medicine at the Rambam Health Care Campus, a position she held for 18 years. Over more than four decades, her main scientific interests included multimodality imaging, in vivo radionuclide quantitation, and imaging of infection and inflammation. She has been involved in the development of hybrid imaging, SPECT/CT and PET/CT, since its beginnings in the late 1990s, and in recent decades in developing guidelines for its clinical implementation. She is the author of four textbooks on Hybrid Imaging and over 220 scientific articles. A founding member of the Israeli Academy of Research in Medicine, she was elected in 2018 as Fellow of the Society of Nuclear Medicine and Molecular Imaging (SNMMI, USA) — the first non-North American to receive this honor — and Honorary Member of the European Association of Nuclear Medicine (EANM) in 2020.

Team AI Leader and Postdoctoral Researcher at University Hospital Würzburg.

Professor Mario Roselli graduated in Medicine and Surgery from the University of Perugia and specialized in Oncology at the University of Rome "Tor Vergata". He obtained a second specialization in Nuclear Medicine at the University of Naples Federico II and completed his training with research periods at the National Cancer Institute (NCI) of the National Institutes of Health (NIH) in Bethesda, USA. He is currently Full Professor of Medical Oncology at the University of Rome "Tor Vergata" and Director of the Postgraduate School in Medicine and Palliative Care. He serves as Chief Physician at the U.O.S.D. Medical Oncology of the Tor Vergata Polyclinic, where he acts as Institutional Referent for the Breast Cancer Oncology Network and Referent for Palliative Care. Professor Roselli specialized in the treatment of neoplasms, medical oncology, chemotherapy, and palliative care. His expertise includes multidisciplinary management of oncology patients, clinical trials, immunotherapy, and personalized medicine. He is an expert in breast oncology, gastrointestinal tumors, melanoma, and lung tumors. Professor Roselli is the author of over 275 international scientific publications and was recognized with the "2020 SITC Team Science Award" from the Society for Immunotherapy of Cancer. He serves as a European Expert for the European Medicines Agency (EMA) and as an oncology consultant for the General Command of the Guardia di Finanza.

Professor Jacob Sosna earned his MD from the Sackler Faculty of Medicine of Tel Aviv University with Distinction in 1989. He has served as Radiology Research Coordinator since 2004, and he established and heads the Experimental CT and acts as a co-director of the Applied Radiology Laboratory. In 2011 Professor Sosna became Chairman of Radiology at Hadassah Hebrew University Medical Center and in 2016 the Director of the Imaging and Nuclear Medicine Division. He serves as Vice Dean of the Hebrew University – Hadassah Faculty of Medicine. Professor Sosna has published over 160 articles in peer-reviewed journals and is an active speaker in international conferences on Radiology and Diagnostic Imaging. He is currently President of the Israeli Radiological Association. Prof. Sosna's research focuses on advancing clinical applications in cutting edge CT technology in collaboration with other experts in image-based diagnosis and therapy in the US and Europe.

Fabio Massimo Zanzotto is a professor at the University of Rome Tor Vergata, coordinating the Human-centric ART group. He specialized in artificial intelligence (AI) and natural language processing (NLP). Since 1998, he has been actively engaged in AI research, focusing on ethical considerations, AI applications in tourism and healthcare, and fundamental AI concepts. He coordinates and has coordinated many research projects, including the European H2020 KATY project and the national Social Tourism e-Platform (STEP), Class-tAIs, and SfidaNow. Zanzotto also oversees collaborations with companies in the natural language processing domain, showcasing his significant impact on both academia and industry. His contributions include work on automatic textual entailment recognition, syntactic parsing, and the application of distributed and distributional models to language syntax and semantics. With over 150 publications in international and national forums, Zanzotto is a prominent figure in the field. He plays an active role in major conference committees (ACL, NAACL, EACL, EmNLP, CoLing, LREC, IJCAI, ECAI, CLEF) and serves as a reviewer for esteemed international journals. He is a member of the Association for Computational Linguistics (ACL) and the Italian Association for Artificial Intelligence, and is a founding member of the Italian Association for Computational Linguistics. Moreover, he contributed to the creation of two spin-offs, Reveal SRL and DevIt SRL.